Zhao Renbin
Direktor/Vorstandsmitglied bei INNOCARE PHARMA LIMITED
Vermögen: 65 Mio $ am 31.05.2024
Aktive Positionen von Zhao Renbin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INNOCARE PHARMA LIMITED | Direktor/Vorstandsmitglied | - | - |
| General Counsel | - | - | |
| Corporate Officer/Principal | 27.09.2019 | - |
Karriereverlauf von Zhao Renbin
Ehemalige bekannte Positionen von Zhao Renbin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
BioDuro (Beijing) Co., Ltd.
 BioDuro (Beijing) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services BioDuro (Beijing) Co., Ltd. operates as a integrated drug discovery outsourcing company that provides integrated research and development services to biopharmaceutical clients. Its services range from medicinal chemistry to discovery biology, pharmacology, drug metabolism and pharmacokinetics (DMPK) and drug safety evaluation. The company was founded in 2006 and is headquartered in Beijing, China. | Corporate Officer/Principal | 01.03.2013 | 01.08.2015 |
| Shenzhou Tianchen Technology, Inc. | Direktor/Vorstandsmitglied | 01.03.2010 | 01.03.2013 |
Ausbildung von Zhao Renbin
| The Johns Hopkins University School of Medicine | Doctorate Degree |
| Tsinghua University | Undergraduate Degree |
Statistik
International
| China | 4 |
| Cayman Islands | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| General Counsel | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INNOCARE PHARMA LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Shenzhou Tianchen Technology, Inc. | |
BioDuro (Beijing) Co., Ltd.
BioDuro (Beijing) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services BioDuro (Beijing) Co., Ltd. operates as a integrated drug discovery outsourcing company that provides integrated research and development services to biopharmaceutical clients. Its services range from medicinal chemistry to discovery biology, pharmacology, drug metabolism and pharmacokinetics (DMPK) and drug safety evaluation. The company was founded in 2006 and is headquartered in Beijing, China. | Commercial Services |
- Börse
- Insiders
- Zhao Renbin
- Erfahrung
